The growth of the Huntington's disease market is expected to be mainly driven by less competitive scenarios, entry of innovative emerging therapies, rising prevalence, and geriatric population
The growth of the endometriosis market is expected to be mainly driven by the entry of novel therapies with better clinical profiles, an upsurge in research and development, and an enriched
The dynamics of the dermatomyositis market are anticipated to change in the coming years owing to the improvement in the rise in a number of healthcare spending across the world and rising cases
The dynamics of the malignant pleural mesothelioma market are anticipated to change in the coming years owing to the increasing awareness and expected increase in investment in the R&D activities.
The overall immune thrombocytopenia market is anticipated to surge owing to the increasing prevalence of the disease along with promising emerging pipeline therapy during the forecasted period